Covered recipient · General Payments record
ELIZABETH SHA DUQUE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,119.15
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $547.54 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $215.78 | 19 |
| PFIZER INC. | $87.42 | 5 |
| Gilead Sciences, Inc. | $79.60 | 3 |
| Ardelyx, Inc. | $47.93 | 2 |
| GENZYME CORPORATION | $41.08 | 1 |
| Phathom Pharmaceuticals, Inc. | $36.46 | 2 |
| Braintree Laboratories, Inc. | $20.05 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $19.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.73 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051905 | CMS |
| ABBVIE INC. | $18.76 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051907 | CMS |
| ABBVIE INC. | $2.00 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051909 | CMS |
| ABBVIE INC. | $9.78 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051911 | CMS |
| ABBVIE INC. | $11.64 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051913 | CMS |
| ABBVIE INC. | $10.97 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051915 | CMS |
| ABBVIE INC. | $17.74 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051917 | CMS |
| ABBVIE INC. | $11.11 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051919 | CMS |
| ABBVIE INC. | $20.68 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051921 | CMS |
| ABBVIE INC. | $2.96 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051923 | CMS |
| ABBVIE INC. | $4.37 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051925 | CMS |
| ABBVIE INC. | $28.22 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051927 | CMS |
| ABBVIE INC. | $14.27 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051929 | CMS |
| ABBVIE INC. | $9.08 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051931 | CMS |
| ABBVIE INC. | $3.24 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051933 | CMS |
| ABBVIE INC. | $7.40 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051935 | CMS |
| ABBVIE INC. | $4.32 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051937 | CMS |
| ABBVIE INC. | $19.31 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051939 | CMS |
| ABBVIE INC. | $9.20 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051941 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $19.22 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147001219 | CMS |
| Ardelyx, Inc. | $22.31 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146725197 | CMS |
| Ardelyx, Inc. | $25.62 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146725199 | CMS |
| Braintree Laboratories, Inc. | $20.05 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125519916 | CMS |
| GENZYME CORPORATION | $41.08 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972119 | CMS |
| Gilead Sciences, Inc. | $31.66 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133674794 | CMS |
| Gilead Sciences, Inc. | $23.79 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133674796 | CMS |
| Gilead Sciences, Inc. | $24.15 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133674798 | CMS |
| PFIZER INC. | $15.51 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131100853 | CMS |
| PFIZER INC. | $21.85 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131286076 | CMS |
| PFIZER INC. | $20.27 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131390436 | CMS |
| PFIZER INC. | $14.46 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131614037 | CMS |
| PFIZER INC. | $15.33 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131152791 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.53 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151162506 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.93 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151162508 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.